PTPA and nasopharyngeal carcinoma: Our results indicate that LB100 is an effective and tolerable agent for sensitizing NPC cells to radiation in mouse models and provides additional support for preclinical exploration of the radiosensitizing properties of LB100 and other PP2A inhibitors.